Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

BeiGene (NASDAQ:ONC) (OTCPK:BEIGF) announced that an advisory committee of the European Medicines Agency (EMA), endorsed its ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

BeiGene's Tevimbra gets a highly sought after recommendation.